Psoriatic Arthritis Market by Mechanism of Action and Type of Disease- Global Industry Analysis and Forecast to 2023

Published On : March 2018 Pages : 105 Category: Pharmaceuticals Report Code : HC03620

Industry Outlook and Trend Analysis

The Psoriatic Arthritis Market has observed substantial development in the recent years and is foreseen to develop significantly in the upcoming years. Psoriatic arthritis is a constant inflammatory disease that influences the distal joints in the body and may likewise influence the back and sacroiliac joints of the pelvis. The worldwide market for psoriatic arthritis is foreseen to witness direct development amid the estimate time frame and factors like the expansion in entrance of biologic treatments are required to enlarge the prospects for development in this market. Furthermore, the current launch of products like Otezla and Stelara is additionally anticipated that would help market development amid the estimate time frame.

Mechanism of Action Outlook and Trend Analysis

The TNF inhibitors assist in suppressing the inflammatory reaction in the patient's body. These inhibitors are used to monitor diseases like rheumatoid arthritis, psoriasis, psoriatic arthritis, seronegative spondyloarthropathies, and inflammatory bowel disease. Besides, its capacity to make use of a focused on system to treat the vast majority of the incendiary and immune system illnesses is essentially in charge of its high share of the market.

Type of Disease outlook ad Trend Analysis

The mild psoriatic arthritis section represents over 60% of all the analysed cases and is the most well-known kind of psoriatic arthritis in patients over the globe. This condition influences under four joints in the body and is otherwise called oligoarticular arthritis.

Regional Outlook and Trend Analysis

Geographically, the worldwide psoriatic arthritis market is sectioned into five expansive districts viz. Latin America, North America, Europe, Asia-Pacific, and the Middle East and Africa. North America is evaluated to lead the worldwide psoriatic arthritis market. Europe market is likewise anticipated to encounter high development soon.

Competitive Insights

This market is essentially ruled by leading players because of their broad item portfolios. The organization that fabricates and markets a medication that can treat psoriatic arthritis, and furthermore show a high wellbeing and adequacy profile, is foreseen to develop over its adversaries amid the estimate time frame. The leading players in the market are Janssen Pharmaceutica NV, AbbVie Inc, Pfizer, Bristol-Myers Squibb, Biogen, Sun Pharmaceutical Industries Ltd, Celgene and Eli Lilly And Company.

The Psoriatic Arthritis market is segmented as follwos-

By Mechanism of Action:

  • Interleukin blockers
  • TNF inhibitors
  • PDE4 inhibitors
  • Others

By Type of Disease:

  • Moderate psoriatic arthritis
  • Severe psoriatic arthritis
  • Mild psoriatic arthritis

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Psoriatic Arthritis Market, By Mechanism of Action, Estimates and Forecast, 2014-2023 ($Million)

·         Interleukin blockers

·         TNF inhibitors

·         PDE4 inhibitors

·         Others

·         Psoriatic Arthritis Market, By Type of Disease, Estimates and Forecast, 2014-2023 ($Million)

·         Moderate psoriatic arthritis

·         Severe psoriatic arthritis

·         Mild psoriatic arthritis

·         Psoriatic Arthritis Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America  Psoriatic Arthritis Market, By Country

§  North America  Psoriatic Arthritis Market, By Mechanism of Action

§  North America  Psoriatic Arthritis Market, By Type of Disease

o    U.S.  Psoriatic Arthritis Market, By Mechanism of Action

o    U.S. Psoriatic Arthritis Market, By Type of Disease

o    Canada  Psoriatic Arthritis Market, By Mechanism of Action

o    Canada  Psoriatic Arthritis Market, By Type of Disease

o    Mexico  Psoriatic Arthritis Market, By Mechanism of Action

o    Mexico  Psoriatic Arthritis Market, By Type of Disease

·         Europe

§  Europe Psoriatic Arthritis Market, By Country

§  Europe Psoriatic Arthritis Market, By Mechanism of Action

§  Europe Psoriatic Arthritis Market, By Type of Disease

o    Germany  Psoriatic Arthritis Market, By Mechanism of Action

o    Germany  Psoriatic Arthritis Market, By Type of Disease

o    France Psoriatic Arthritis Market, By Mechanism of Action

o    France Psoriatic Arthritis Market, By Type of Disease

o    UK   Psoriatic Arthritis Market, By Mechanism of Action

o    UK   Psoriatic Arthritis Market, By Type of Disease

o    Italy   Psoriatic Arthritis Market, By Mechanism of Action

o    Italy   Psoriatic Arthritis Market, By Type of Disease

o    Spain   Psoriatic Arthritis Market, By Mechanism of Action

o    Spain   Psoriatic Arthritis Market, By Type of Disease

o    Rest of Europe   Psoriatic Arthritis Market, By Mechanism of Action

o    Rest of Europe   Psoriatic Arthritis Market, By Type of Disease

·         Asia-Pacific

§  Asia-Pacific   Psoriatic Arthritis Market, By Country

§  Asia-Pacific   Psoriatic Arthritis Market, By Mechanism of Action

§  Asia-Pacific   Psoriatic Arthritis Market, By Type of Disease

o    Japan   Psoriatic Arthritis Market, By Mechanism of Action

o    Japan   Psoriatic Arthritis Market, By Type of Disease

o    Australia   Psoriatic Arthritis Market, By Mechanism of Action

o    Australia   Psoriatic Arthritis Market, By Type of Disease

o    India   Psoriatic Arthritis Market, By Mechanism of Action

o    India   Psoriatic Arthritis Market, By Type of Disease

o    South Korea   Psoriatic Arthritis Market, By Mechanism of Action

o    South Korea   Psoriatic Arthritis Market, By Type of Disease

o    Rest of Asia-Pacific   Psoriatic Arthritis Market, By Mechanism of Action

o    Rest of Asia-Pacific   Psoriatic Arthritis Market, By Type of Disease

·         Rest of the World

§  Rest of the World   Psoriatic Arthritis Market, By Country

§  Rest of the World   Psoriatic Arthritis Market, By Mechanism of Action

§  Rest of the World   Psoriatic Arthritis Market, By Type of Disease

o    Brazil   Psoriatic Arthritis Market, By Mechanism of Action

o    Brazil   Psoriatic Arthritis Market, By Type of Disease

o    South Africa   Psoriatic Arthritis Market, By Mechanism of Action

o    South Africa   Psoriatic Arthritis Market, By Type of Disease

o    Saudi Arabia   Psoriatic Arthritis Market, By Mechanism of Action

o    Saudi Arabia   Psoriatic Arthritis Market, By Type of Disease

o    Turkey   Psoriatic Arthritis Market, By Mechanism of Action

o    Turkey   Psoriatic Arthritis Market, By Type of Disease

o    United Arab Emirates   Psoriatic Arthritis Market, By Mechanism of Action

o    United Arab Emirates   Psoriatic Arthritis Market, By Type of Disease

o    Others   Psoriatic Arthritis Market, By Mechanism of Action

o    Others   Psoriatic Arthritis Market, By Type of Disease

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Expansion in entrance of biologic treatments

3.2.3.  Restraints

3.2.4.  Opportunities

3.2.4.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Psoriatic Arthritis Market, By Mechanism Of Action

4.1.       Introduction

4.2.       Global Psoriatic Arthritis Sales, Revenue and Market Share by Mechanism Of Action(2014-2017)

4.2.1.  Global Psoriatic Arthritis Sales and Sales Share by Mechanism Of Action(2014-2017)

4.2.2.  Global Psoriatic Arthritis Revenue and Revenue Share by Mechanism Of Action(2014-2017)

4.3.       Psoriatic Arthritis Market   Assessment and Forecast, By Mechanism of Action, 2014-2023

4.4.       Interleukin blockers

4.4.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

4.5.       TNF inhibitors

4.5.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

4.6.       PDE4 inhibitors

4.6.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

4.7.       Others

4.7.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

5.       Psoriatic Arthritis Market, By Type of disease

5.1.       Introduction

5.2.       Global Psoriatic Arthritis Sales, Revenue and Market Share by Type of disease (2014-2017)

5.2.1.  Global Psoriatic Arthritis Sales and Sales Share by Type of disease (2014-2017)

5.2.2.  Global Psoriatic Arthritis Revenue and Revenue Share by Type of disease (2014-2017)

5.3.       The Psoriatic Arthritis Market   Assessment and Forecast, By Type of disease, 2014-2023

5.4.       Moderate psoriatic arthritis

5.4.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

5.5.       Severe psoriatic arthritis

5.5.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

5.6.       Mild psoriatic arthritis

5.6.1.  Market Assessment and Forecast, By Region, 2014-2023($Million)

6.       Psoriatic Arthritis Market, By Region

6.1.       Introduction

6.2.       Psoriatic Arthritis Market Assessment and Forecast, By Region, 2014-2023 ($Million)

6.3.       Global Psoriatic Arthritis Sales, Revenue and Market Share by Regions

6.3.1.  Global Psoriatic Arthritis Sales by Regions (2014-2017)

6.3.2.  Global Psoriatic Arthritis Revenue by Regions (2014-2017)

6.4.       North America

6.4.1.  North America Psoriatic Arthritis Sales and Growth Rate (2014-2017)

6.4.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

6.4.3.  Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.4.4.  Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.4.5.  U.S.

6.4.5.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.4.5.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.4.6.  Canada

6.4.6.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.4.6.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.4.7.  Mexico

6.4.7.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.4.7.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.       Europe

6.5.1.  Europe Psoriatic Arthritis Sales and Growth Rate (2014-2017)

6.5.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

6.5.3.  Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.4.  Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.5.  Germany

6.5.5.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.5.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.6.  France

6.5.6.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.6.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.7.  UK

6.5.7.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.7.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.8.  Italy

6.5.8.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.8.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.9.  Spain

6.5.9.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.9.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.5.10.      Rest of Europe

6.5.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.5.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.       Asia-Pacific

6.6.1.  Asia-Pacific Psoriatic Arthritis Sales and Growth Rate (2014-2017)

6.6.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

6.6.3.  Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.4.  Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.5.  Japan

6.6.5.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.5.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.6.  China

6.6.6.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.6.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.7.  Australia

6.6.7.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.7.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.8.  India

6.6.8.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.8.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.9.  South Korea

6.6.9.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.9.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.6.10.      Rest of Asia-Pacific

6.6.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.6.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.       Rest of the World

6.7.1.  Rest of the World Psoriatic Arthritis Sales and Growth Rate (2014-2017)

6.7.2.  Market Assessment and Forecast, By Country, 2014-2023($Million)

6.7.3.  Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.4.  Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.5.  Brazil

6.7.5.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.5.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.6.  Turkey

6.7.6.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.6.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.7.  Saudi Arabia

6.7.7.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.7.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.8.  South Africa

6.7.8.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.8.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.9.  United Arab Emirates

6.7.9.1.    Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.9.2.    Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

6.7.10.      Others

6.7.10.1. Market Assessment and Forecast, By Mechanism of Action, 2014-2023($Million)

6.7.10.2. Market Assessment and Forecast, By Type of disease, 2014-2023($Million)

7.       Company Profiles

7.1.       Janssen Pharmaceutica NV

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Strategic Developments

7.1.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.2.       AbbVie Inc

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Strategic Developments

7.2.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.3.       Pfizer

7.3.1.  Business Overview

7.3.2.  Product  Portfolio

7.3.3.  Strategic Developments

7.3.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.4.       Bristol-Myers Squibb

7.4.1.  Business Overview

7.4.2.  Product Portfolio

7.4.3.  Strategic Developments

7.4.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.5.       Biogen

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.5.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.6.       Sun Pharmaceutical Industries Ltd

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.6.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.7.       Celgene

7.7.1.  Business Overview

7.7.2.  Product Portfolio

7.7.3.  Strategic Developments

7.7.4.  Psoriatic Arthritis Sales, Revenue and Market Share

7.8.       Eli Lilly And Company

7.8.1.  Business Overview

7.8.2.  Product  Portfolio

7.8.3.  Strategic Developments

7.8.4.  Psoriatic Arthritis Sales, Revenue and Market Share

8.       Global Psoriatic Arthritis Market Competition, by Manufacturer

8.1.       Global Psoriatic Arthritis Sales and Market Share by Manufacturer (2016-2017)

8.2.       Global Psoriatic Arthritis Revenue and Market Share by Manufacturer (2016-2017)

8.3.       Top 5 Psoriatic Arthritis Manufacturer Market Share

8.4.       Market Competition Trend

List of Tables and Figures

*You can glance through the list of Tables and Figures when you view the sample copy of Psoriatic Arthritis Market.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*